Floatz logo

Pneumococcal Polyvalent Vaccine

Pregerminal Center Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

National Cancer Institute (NCI)vaccinePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Pregerminal Center Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma cohort.

Asset / SponsorPhaseRating
cc-5013
National Cancer Institute (NCI)
Phase 2CCC

Same molecule, other indications

Pneumococcal Polyvalent Vaccine is also rated in:

plasma cell myelomaDormant
BB
Indicative ·
70 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
CCC
Indicative ·
52 / 100
View asset →
infectious diseaseDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →